A Cumulative Dose Study to Evaluate the Safety and Efficacy of Albuterol in a Dry Powder Inhaler and an HFA MDI (Hydrofluoroalkane Metered Dose Inhaler)
Clinical trial NCT01056159 · COMPLETED
Trial details
- NCT number
- NCT01056159
- Sponsor
- Teva Branded Pharmaceutical Products R&D, Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2010-01-01
- Primary completion
- 2010-06-01
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.